INTRODUCTION
CH 1: Historical Perspective
SECTION I: CHEMISTRY, METABOLISM, AND CIRCULATION
CH 2: Vitamin D Metabolism
CH 3: Photobiology of Vitamin D
CH 4: The Vitamin D-25 Hydroxylase
CH 5: The 25-Hydroxyvitamin D 1-alpha-Hydroxylase
CH 6: The 25-Hydroxyvitamin D 24-Hydroxylase
CH 7: Mutant Mouse Models of Vitamin D Metabolic Enzymes
CH 8: Vitamin D Binding Protein
CH 9: New Aspects of DBP
CH 10: Endocytic Pathways for 25-(OH) Vitamin D3
SECTION II: MECHANISM OF ACTION
CH 11: The Vitamin D Receptor
CH 12: Vitamin D Receptor Promoter and Regulation of Receptor Expression
CH 13: Nuclear Vitamin D Receptor: Structure-Function, Molecular Control of Gene Transcription, and Novel Bioactions
CH 14: Vitamin D Receptor Cofactors: Function, Regulation, and Selectivity
CH 15: VDR LBD Crystal Structures
CH 16: Comodulators of VDR-Mediated: Gene Expression
CH 17: Promoter Targeting of VDR Through A Chromatin Remodeling Complex
CH 18: Molecular Basis of the Diversity of Vitamin D Target Genes
CH 19: Intranuclear Organization of the Regulatory Machinery for Vitamin D-Mediated Control of Skeletal Gene
CH 20: Mouse Models of Vitamin D Receptor Ablation
CH 21: Intranuclear Vitamin D Response Element Binding
CH 22: VDR and RXR Subcellular Trafficking
CH 23: 1a,25(OH)2¡Vvitamin D3 mediated rapid and genomic responses are dependent upon critical structure-function relationships for both the ligand and receptor(s)
SECTION III: MINERAL HOMEOSTASIS
CH 24: Vitamin D and the Intestinal Absorption of Calcium: A View and Overview
CH 25: Intestinal Calcium Absorption: Lessons from Knock Out Mice and Men
CH 26: Phosphate Homeostasis
CH 27: Mineralization
CH 28: Modeling and Remodeling: How Bone Cells Work Together
CH 29: Vitamin D and the Kidney
CH 30: Vitamin D and the Parathyroids
CH 31: Calcium-Sensing Receptor
SECTION IV: TARGET ORGANS AND ACTIONS:
A. Organs/Tissues
CH 32: Bone
CH 33: Cartilage and Vitamin D: Genomic and Nongenomic Regulation
CH 34: Dento-Alveolar Bone Complex and Vitamin D
CH 35: Role in Skin and Hair
CH 36: Regulation of Immune Responses by Vitamin D Receptor Ligands
CH 37: Osteoblasts
CH 38: Vitamin D and Osteoclastogenesis
CH 39: Vitamin D Control of the Calcitonin Gene in Thyroid C Cells
CH 40: Vitamin D Regulation of Type I Collagen Expression in Bone
CH 41: Target Genes: Bone Proteins
CH 42: The Calbindins: Calbindin-D9k and Calbindin-D28k
CH 43: Target Genes
CH 44: Effects of 1,25-Dihydroxyvitamin D3 on Voltage-Sensitive Calcium Channels in the Vitamin D Endocrine System
CH 45: Vitamin D and the Cellular Response to Oxidative Stress
SECTION V: HUMAN PHYSIOLOGY
CH 46: Vitamin D: Role in the Calcium Economy
CH 47: Effects of Race, Geography, Body Habitus, Diet, and Exercise on Vitamin D Metabolism
CH 48: Perinatal Vitamin D Actions
CH 49: Vitamin D Deficiency and Calcium Absorption During Infancy and Childhood
CH 50: Vitamin D Metabolism and Aging
CH 51: Vitamin D Metabolism in Pregnancy and Lactation
CH 52: Vitamin D and Reproductive Organs
CH 53: Vitamin D Receptor as a Sensor for Toxic Bile Acids
CH 54: The Renin-Angiotensin System
CH 55: Vitamin D and Muscle
CH 56: Vitamin D and Cardiovascular Medicine
SECTION VI: DIAGNOSIS AND MANAGEMENT
CH 57: Approach to the Patient with Metabolic Bone Disease
CH 58: Detection of Vitamin D and Its Major Metabolites
CH 59: Bone Histomorphometry
CH 60: Radiology of Rickets and Osteomalacia
CH 61: The Pharmacology of Vitamin D, Including Fortification Strategies
SECTION VII: DISORDERS OF THE VITAMIN D: ENDOCRINE SYSTEM
CH 62: How to Define Normal Values for Serum Concentrations of 25-Hydroxyvitamin D? An Overview
CH 63: Vitamin D and the Pathogenesis of Rickets and Osteomalacia
CH 64: The Hypocalcemic Disorders: Differential Diagnosis and Therapeutic Use of Vitamin D
CH 65: Vitamin D Deficiency and Nutritional Rickets in Children
CH 66: Vitamin D Insufficiency in Adults and the Elderly
CH 67: Vitamin D and Osteoporosis
CH 68: Genetic Vitamin D Receptor Polymorphisms and Risk of
CH 69: Clinical Disorders of Phosphate Homeostasis
CH 70: Disorders of Phosphate Metabolism: Autosomal Dominant Hypophosphatemic Rickets, Tumor Induced Osteomalacia, Fibrous Dysplasia, and the Pathophysiological Relevance of FGF23 TIO, ADDR FGF-23
CH 71: Vitamin D Pseudodeficiency
CH 72: Hereditary 1,25-Dihydroxyvitamin D Resistant Rickets
CH 73: Glucocorticoids and Vitamin D
CH 74: Drug and Hormone Effects on Vitamin D Metabolism
CH 75: Bone Disorders Associated with Gastrointestinal & Hepatobiliary Disease
CH 76: Vitamin D and Renal Failure
CH 77: Idiopathic Hypercalciuria and Nephrolithiasis
CH 78: Hypercalcemia Due to Vitamin D Toxicity
CH 79: Extra-renal 1„´-hydroxylase Activity and Human Disease
SECTION VIII: NEW VITAMIN D ANALOGS
CH 80: Overview: Rational Design of 1a,25-Dihydroxyvitamin D3 Analogs (Deltanoids)
CH 81: Analog Metabolism
CH 82: Mechanisms for the Selective Actions of Vitamin D Analogs
CH 83: Molecular Basis for Differential Action of Vitamin D Analogs
CH 84: Development of New Vitamin D Analogs
CH 85: Geminis: The 1,25-dihydroxy Vitamin D Analogs with Two Side-Chains
CH 86: Development of OCT and ED-71
CH 87: 2-Carbon-Modified Analogs of 19-Nor- 1a,25-Dihydroxyvitamin D3
CH 88: Non-steroidal Analogs
SECTION IX: VITAMIN D AND CANCER
CH 89: Vitamin D: Cancer and Differentiation
CH 90: Vitamin D, Sunlight, and the Natural History of Prostate Cancer
CH 91: Epidemiology of Cancer Risk: Vitamin D and Calcium
CH 92: Differentiation and the Cell Cycle
CH 93: Vitamin D and Breast Cancer
CH 94: Vitamin D and Prostate Cancer
CH 95: Vitamin D and Colon Cancer
CH 96: Vitamin D and Hematological: Malignancy
CH 97: Clinical Development of Calcitriol and Calcitriol Analogs in Oncology: Progress and Considerations for Future Development
SECTION X: EMERGING USES:
Overview: Vitamin D Vs. Calcium Effects
CH 98: Vitamin D3: Autoimmunity and Immunosuppression
CH 99: Vitamin D and Diabetes
CH 100: Vitamin D, A Neuroactive Hormone: From Brain Development to Neurodegenerative Disorders
CH 101: Psoriasis and Other Skin Diseases
CH 102: Muscles and Falls
CH 103: Renal Failure and Secondary Hyperparathyroidism
CH 104: Inhibition of Benign Prostatic Hyperplasia by Vitamin D Receptor Ligands